weightloss.com.au
Head-to-head comparison

Compare Wegovy vs. Ozempic

Wegovy and Ozempic contain the same active ingredient (semaglutide) made by the same company (Novo Nordisk), but at different doses for different purposes. Ozempic (up to 1mg) is TGA-approved for type 2 diabetes and PBS subsidised at $32/month. Wegovy (up to 2.4mg) is TGA-approved for weight management but currently costs $350-460/month privately, with PBS listing pending.

Wegovy logo
Wegovy
Semaglutide 0.25-2.4mg
~15-17%
avg. weight loss
$350-460 private
per month
Ozempic logo
Ozempic
Semaglutide 0.25-1mg
~15%
avg. weight loss
$32 PBS / $134 private
per month

Compare Wegovy vs Ozempic at a Glance

Drug class
Wegovy
GLP-1 receptor agonist
Ozempic
GLP-1 receptor agonist
How taken
Wegovy
Weekly injection (oral pill in US only)
Ozempic
Weekly injection
Avg. weight loss
Wegovy
~15-17%
Ozempic
~15%
First approved
Wegovy
2021 (FDA), 2024 (TGA)
Ozempic
2017 (FDA), 2019 (TGA)
AU cost/month
Wegovy
$350-460 private
Ozempic
$32 PBS / $134 private
PBS status
Wegovy
Pending (Jan 2026 rec.)
Ozempic
Yes (diabetes only)
Prescription needed?
Wegovy
Yes
Ozempic
Yes
AU supply status
Wegovy
Stable
Ozempic
Constrained (improving)

Compare Wegovy vs Ozempic Cost in Australia

Wegovy
$350–460
$350-460 private
per month (PBS: Pending (Jan 2026 rec.))
Ozempic
$32–134
$32 PBS / $134 private
per month (PBS: Yes (diabetes only))

Private prescription cost per month in AUD.

Compare Wegovy vs Ozempic Weight Loss Efficacy

Wegovy
~15-17%
avg. weight loss (12-21%)
Ozempic
~15%
avg. weight loss (10-17%)

Wegovy Clinical Trials

STEP 1

14.9% weight loss vs 2.4% placebo

68 weeksn=1,961

STEP UP (7.2mg)

21% weight loss

72 weeks

SELECT

20% reduction in CV events

4+ yearsn=17,604

OASIS-4 (pill)

16.6% weight loss (oral form)

64 weeks

Ozempic Clinical Trials

SUSTAIN 1-12

5-7kg weight loss (diabetes population)

30-104 weeks

STEP 1 (higher dose)

14.9% body weight reduction

68 weeks

Clinical trial data at highest approved doses. Individual results vary.

Compare Wegovy vs Ozempic Side Effects

Wegovy

Very common

  • Nausea (up to 44%)
  • Diarrhoea
  • Vomiting
  • Constipation

Common

  • Headache
  • Abdominal pain
  • Fatigue
  • Dyspepsia
  • Injection site reactions

Serious (rare)

  • Pancreatitis
  • Gallbladder disease
  • Acute kidney injury
  • Suicidal ideation (under investigation)
  • Potential fracture risk (Dec 2025 warning)

Ozempic

Very common

  • Nausea (20-44%)
  • Diarrhoea (8-30%)
  • Vomiting

Common

  • Constipation
  • Abdominal pain
  • Headache
  • Fatigue
  • Injection site reactions

Serious (rare)

  • Pancreatitis
  • Gallbladder problems
  • Kidney injury
  • Thyroid tumours (animal studies)
  • Suicidal ideation (under investigation)

Compare How Wegovy and Ozempic Work

Wegovy

GLP-1 receptor agonist

Same mechanism as Ozempic but at higher dose (2.4mg vs 1mg) optimised for weight management. Mimics GLP-1 hormone, reducing appetite, slowing gastric emptying, and improving satiety. The oral pill (US only) uses SNAC technology to protect the molecule in the stomach.

Ozempic

GLP-1 receptor agonist

Mimics the natural hormone GLP-1. Slows gastric emptying, increases insulin production, reduces glucagon, and acts on appetite centres in the brain to reduce hunger. Once-weekly injection in abdomen, thigh, or upper arm.

Compare Wegovy vs Ozempic Dosing Schedule

Wegovy

Weekly injection (oral pill in US only)

DosePeriodNote
0.25mgWeeks 1-4Starting dose
0.5mgWeeks 5-8Escalation
1mgWeeks 9-12Escalation
1.7mgWeeks 13-16Escalation
2.4mgWeek 17+Maintenance dose

Ozempic

Weekly subcutaneous injection

DosePeriodNote
0.25mgWeeks 1-4Starting dose
0.5mgWeeks 5-8Dose escalation
1mgWeek 9+Maintenance dose

Compare Wegovy vs Ozempic Australian Regulatory Status

Wegovy

TGA Status
Registered on ARTG for chronic weight management and CV risk reduction
PBS Listed
PBAC recommended Jan 2026; price negotiation underway
PBS Criteria
BMI ≥35 (≥32.5 for Asian, Aboriginal, Torres Strait Islander) + established CVD
Supply Status
More stable supply than Ozempic as of early 2026
Oral Pill
Not available in Australia. Launched in US Jan 2026.

Ozempic

TGA Status
Registered on ARTG for type 2 diabetes
PBS Listed
Yes, for type 2 diabetes (Authority Required)
Off-label Use
Restricted since Oct 2024 for new weight loss prescriptions
Supply Status
Ongoing shortage since 2022; improving but not resolved
Compounding
Compounded versions banned from 1 October 2024

This website is for informational and research purposes only.

We are not medical professionals and nothing on this page constitutes medical advice, diagnosis, or treatment. Always consult a qualified doctor or specialist before making any decisions about medication.

The weight loss medication landscape in Australia is changing rapidly. Information on this page may become outdated without notice. Data sourced from the TGA, FDA, MHRA, NICE, PBAC, Australian Prescriber, Obesity Evidence Hub, and clinical trial publications. Last reviewed March 2026.